Skip to content

Logs: Helen Curtis

The following is a list of all job requests run via OpenSAFELY by Helen Curtis.
Status Organisation Project Workspace Request ID Backend Jobs Started View request
Succeeded Bennett Institute OpenSAFELY Interactive test-interactive 7272 TPP 1/1 3 years, 10 months ago 27 April 2022 10:16:45 UTC View, Job request 7272
Succeeded Bennett Institute OpenSAFELY Interactive test-interactive 7261 TPP 1/1 3 years, 10 months ago 27 April 2022 07:52:21 UTC View, Job request 7261
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 7236 TPP 3/3 3 years, 10 months ago 26 April 2022 14:21:09 UTC View, Job request 7236
Failed Bennett Institute OpenSAFELY Interactive test-interactive 7159 TPP 0/1 3 years, 10 months ago 22 April 2022 09:14:29 UTC View, Job request 7159
Succeeded Bennett Institute OpenSAFELY Interactive test-interactive 7148 TPP 1/1 3 years, 10 months ago 21 April 2022 18:10:24 UTC View, Job request 7148
Failed Bennett Institute OpenSAFELY Interactive test-interactive 7117 TPP 0/1 3 years, 10 months ago 21 April 2022 10:13:33 UTC View, Job request 7117
Succeeded Bennett Institute OpenSAFELY Interactive test-interactive 7109 TPP 1/1 3 years, 10 months ago 21 April 2022 09:31:52 UTC View, Job request 7109
Failed Bennett Institute OpenSAFELY Interactive test-interactive 7107 TPP 0/1 - View, Job request 7107
Succeeded Bennett Institute OpenSAFELY Interactive test-interactive 7079 TPP 1/1 3 years, 10 months ago 20 April 2022 13:53:11 UTC View, Job request 7079
Succeeded Bennett Institute OpenSAFELY Interactive test-interactive 7068 TPP 1/1 3 years, 10 months ago 20 April 2022 10:13:04 UTC View, Job request 7068
Failed Bennett Institute OpenSAFELY Interactive test-interactive 7049 TPP 0/1 3 years, 11 months ago 19 April 2022 17:00:24 UTC View, Job request 7049
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 6295 TPP 1/1 3 years, 11 months ago 25 March 2022 13:17:57 UTC View, Job request 6295
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 6293 TPP 1/1 3 years, 11 months ago 25 March 2022 13:03:48 UTC View, Job request 6293
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 6290 TPP 1/1 3 years, 11 months ago 25 March 2022 11:57:46 UTC View, Job request 6290
Failed Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 6287 TPP 0/1 3 years, 11 months ago 25 March 2022 11:11:25 UTC View, Job request 6287
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 6270 TPP 1/1 3 years, 11 months ago 24 March 2022 18:16:30 UTC View, Job request 6270
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 6260 TPP 1/1 3 years, 11 months ago 24 March 2022 15:11:50 UTC View, Job request 6260
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 6259 TPP 1/1 3 years, 11 months ago 24 March 2022 15:10:00 UTC View, Job request 6259
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 6247 TPP 1/1 3 years, 11 months ago 24 March 2022 11:38:44 UTC View, Job request 6247
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-sus 6207 TPP 2/2 3 years, 11 months ago 23 March 2022 12:37:42 UTC View, Job request 6207
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-further-testing 5378 TPP 5/5 4 years, 1 month ago 10 February 2022 14:23:27 UTC View, Job request 5378
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-not-weekly-test 5211 TPP 5/5 4 years, 1 month ago 04 February 2022 07:33:07 UTC View, Job request 5211
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-not-weekly-test 5202 TPP 1/1 4 years, 1 month ago 03 February 2022 19:27:36 UTC View, Job request 5202
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 mabs-not-weekly-test 5201 TPP 4/4 4 years, 1 month ago 03 February 2022 18:55:23 UTC View, Job request 5201
Succeeded Bennett Institute Trends and clinical characteristics of COVID-19 vaccine recipients covid-vaccine-preliminary-study-master 4460 TPP 3/3 4 years, 3 months ago 30 November 2021 15:16:40 UTC View, Job request 4460